Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > South America
Category: All Categories > Life Sciences > Pharmaceuticals > Manufacturing, Packaging & Detailing
(95 reports matching your criteria)
 
< prev 1    3  4  
Venezuela Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... and effective communication with the Venezuelan government are vital for the survivalof domestic pharmaceutical companies. As the Venezuelan government tries to increase access tomedicines, more co-ordination with drug producers to address these issues will become ...  |  read more...
$1,295.00
Brazil Pharmaceuticals and Healthcare Report Q2 2014
3/19/2014 | published by: Business Monitor International
... opportunities for drugmakers and healthcare serviceproviders. However, given the Brazilian government's protectionist measures in the pharmaceutical sector,we believe local drugmakers will outpace multinationals. Headline Expenditure Projections Pharmaceuticals: BRL57.0bn (US$26.4bn) in 2013 to BRL61.6bn (US$26.2bn) in ...  |  read more...
$1,295.00
Chile Pharmaceuticals and Healthcare Report Q2 2014
3/19/2014 | published by: Business Monitor International
... the country. The tightenedbioequivalent regulations will boost genuine medicine sales and force similares out of the market. However,we believe the current lack of vigilance in bioequivalence regulations in Chile has allowed the proliferationof low quality ...  |  read more...
$1,295.00
Peru Pharmaceuticals and Healthcare Report Q2 2014
3/12/2014 | published by: Business Monitor International
... companies can generate rapid sales growth due to the lack of mandatory medicine pricingsystem in Peru. More stringent quality controls, relatively weak domestic pharmaceutical industry, ongoingliberalisation of bilateral trade agreements and the recognition of 'High ...  |  read more...
$1,295.00
Argentina Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... biotechnology sector remain scant, are scattered across the country and thereis a lack of continuity in comparison with its neighbour Brazil. The long-term absence of orthodoxeconomic policy in the country will also hinder private investment ...  |  read more...
$1,295.00
Colombia Pharmaceuticals and Healthcare Report Q2 2014
2/21/2014 | published by: Business Monitor International
... constrained over the comingyears. On the positive side, we expect volume sales will be boosted and partially offset the negative impactsof further drug price cuts. Colombia's relatively advanced drug reimbursement system will still offerrevenue-generating opportunities ...  |  read more...
$1,295.00
PharmaSphere: Pharmaceutical and Healthcare Deal Trends in Latin America: 2008 - 2012
1/31/2014 | published by: GlobalData
... that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships. The report also provides understanding on the ...  |  read more...
$2,995.00
Pharmaceuticals in Brazil: ISIC 2423
1/27/2014 | published by: Euromonitor International
... at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing ...  |  read more...
$600.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
10/14/2013 | published by: GlobalData
... information and analysis regarding the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, ...  |  read more...
$1,995.00
Chemical & Pharmaceutical Plant Construction in Colombia to 2017: Market Databook
8/28/2013 | published by: Timetric
... chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
$500.00
PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
7/31/2013 | published by: GlobalData
... The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than ...  |  read more...
$4,995.00
BRIC: pharmahandbook
6/1/2013 | published by: VOI Consulting
... on the structural, regulatory and commercial aspects of the biopharmaceutical markets in each country, pharmahandbook’s 2013 BRIC report provides you with what you need to know in order to capi-talize on these vitally important but ...  |  read more...
$905.00
Chemical & Pharmaceutical Plant Construction in Chile to 2017: Market Databook
5/13/2013 | published by: Timetric
... chemical & pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the ...  |  read more...
$500.00
Healthcare, Regulatory and Reimbursement Landscape - Argentina
4/22/2013 | published by: GlobalData
... regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the ...  |  read more...
$1,995.00
Branded Generics: Strategies and Tactics for Winning in Latin America
4/1/2013 | published by: FirstWord
... of investing in Latin America’s burgeoning branded generics market, there are hurdles. For pharma companies seeking entry into the diverse, complex and emerging Latin American market, challenges exist on all fronts. Consumers have an embedded ...  |  read more...
$1,995.00
Brazil Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... and pharmaceutical industry to reduce thefinancial burden of diseases, and the country's private healthcare sectors provide opportunities forforeign companies. However, the increasing drug rebate level has significantly undermined the profitsrecorded by generic drugmakers. The more ...  |  read more...
$1,295.00
Driving Brand Value in Emerging Markets -- winning strategies and tactics
1/1/2013 | published by: FirstWord
... in sales versus double-digit performance in emerging markets. Yet much as the BRIC (Brazil, Russia, India, China) countries and others hold enormous potential, success has not always been assured. What defence mechanisms exist for brands ...  |  read more...
$495.00
The 2013 Import and Export Market for Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... market in Latin America face a number of questions. Which countries are supplying medicaments containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins to Latin America? What is the dollar value of ...  |  read more...
$325.00
The 2013 Import and Export Market for Medicaments Containing Antibiotics (Except Penicillins and Streptomycins) Excluding Those in Dosage Form or Retail Packings in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing antibiotics (except penicillins and streptomycins) excluding those in dosage form or retail packings to Latin America? What is ...  |  read more...
$325.00
The 2013 Import and Export Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... planners approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives to Latin America? ...  |  read more...
$325.00
The 2013 Import and Export Market for Medicaments Containing Insulin Excluding Those in Dosage Form or Retail Packings in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... Latin America face a number of questions. Which countries are supplying medicaments containing insulin excluding those in dosage form or retail packings to Latin America? What is the dollar value of these imports? How much ...  |  read more...
$325.00
The 2013 Import and Export Market for Medicaments Containing Insulin in Dosage Form or Retail Packings in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... face a number of questions. Which countries are supplying medicaments containing insulin in dosage form or retail packings to Latin America? What is the dollar value of these imports? How much do the imports of ...  |  read more...
$325.00
The 2013 Import and Export Market for Medicaments Containing Penicillins or Streptomycins or Their Derivatives in Dosage Form or Retail Packings in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... the market in Latin America face a number of questions. Which countries are supplying medicaments containing penicillins or streptomycins or their derivatives in dosage form or retail packings to Latin America? What is the dollar ...  |  read more...
$325.00
The 2013 Import and Export Market for Medicaments Containing Penicillins, Streptomycins, or Their Derivatives Excluding Those in Dosage Form or Retail Packings in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... approaching the market in Latin America face a number of questions. Which countries are supplying medicaments containing penicillins, streptomycins, or their derivatives excluding those in dosage form or retail packings to Latin America? What is ...  |  read more...
$325.00
The 2013 Import and Export Market for Pharmaceutical Goods Excluding Medicaments in Latin America
1/1/2013 | published by: Icon Group International, Inc.
... Which countries are supplying pharmaceutical goods excluding medicaments to Latin America? What is the dollar value of these imports? How much do the imports of pharmaceutical goods excluding medicaments vary from one country to another ...  |  read more...
$325.00
< prev 1    3  4